Barnett & Company Has Increased By $954,000 Its Calumet Specialty Prods Ptnr (CLMT) Stake; Nuance Investments Has Boosted Clorox Co Del (CLX) Stake By $607,500

The Clorox Company (NYSE:CLX) Logo

Nuance Investments Llc increased Clorox Co Del (CLX) stake by 10.59% reported in 2018Q3 SEC filing. Nuance Investments Llc acquired 4,050 shares as Clorox Co Del (CLX)’s stock rose 7.73%. The Nuance Investments Llc holds 42,291 shares with $6.36 million value, up from 38,241 last quarter. Clorox Co Del now has $19.89 billion valuation. The stock decreased 0.32% or $0.5 during the last trading session, reaching $155.16. About 156,944 shares traded. The Clorox Company (NYSE:CLX) has risen 12.45% since February 11, 2018 and is uptrending. It has outperformed by 12.45% the S&P500. Some Historical CLX News: 02/05/2018 – Clorox 3Q Gross Margin Fell 120 Basis Points to 42.8%; 27/03/2018 – Hemet Valley Medical Center Implements Cutting-edge UV Technology to Enhance Patient Safety and Help Eradicate Healthcare-Associated Infections; 08/05/2018 – Prebiotics and Probiotics Team Up in Renew Life’s First Organic Supplement; 02/05/2018 – Clorox Now Sees FY18 Sales Up About 3%; Had Seen Up 1%-3%; 20/03/2018 – VANTERRA CAPITAL SAYS ADDITIONAL TERMS OF TRANSACTION WERE NOT DISCLOSED; 12/03/2018 – Clorox Expects to Fund Nutranext Acquisition Through Combination of Available Cash and Debt Financing; 20/03/2018 – VANTERRA CAPITAL,WM PARTNERS SELLS PLATFORM TO CLOROX FOR $700M; 07/05/2018 – Former CFO Centered Clorox’s Business on the Domestic Market; 22/05/2018 – P&G, Colgate and Clorox were last this cheap on a relative basis to the market seven to nine years ago; 30/04/2018 – Clorox at Bernstein Strategic Decisions CEO Conference May 30

Barnett & Company Inc increased Calumet Specialty Prods Ptnr (CLMT) stake by 64.04% reported in 2018Q3 SEC filing. Barnett & Company Inc acquired 159,000 shares as Calumet Specialty Prods Ptnr (CLMT)’s stock declined 56.74%. The Barnett & Company Inc holds 407,300 shares with $2.61M value, up from 248,300 last quarter. Calumet Specialty Prods Ptnr now has $251.05 million valuation. The stock decreased 0.65% or $0.0208 during the last trading session, reaching $3.1892. About 62,911 shares traded. Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT) has declined 63.03% since February 11, 2018 and is downtrending. It has underperformed by 63.03% the S&P500. Some Historical CLMT News: 19/03/2018 – Calumet Specialty Prods Sees Commensurate Decrease in Those Line Items for FY 2017; 19/03/2018 – Calumet Specialty Prods Continues to Integrate Enterprise Resource Planning System; 08/03/2018 – CALUMET SPECIALTY PRODUCTS PARTNERS LP – EXTENDED ITS CORPORATE REVOLVER FOR A NEW FIVE-YEAR TERM; 14/05/2018 – Calumet Specialty Products Partners, L.P. to File its Form 10-Q on May 15th and Will Host First Quarter Financial Results Conference Call on May 16th; 26/04/2018 – Explosion rocks Calumet Superior, Wisconsin refinery -local media; 26/04/2018 – EXPLOSION ROCKS CALUMET SUPERIOR WISCONSIN REFINERY -LOCAL MEDIA; 08/03/2018 – CALUMET SPECIALTY PRODUCTS PARTNERS, L.P. REPORTS REDEMPTION OF; 19/03/2018 – Calumet Specialty Products Partners, L.P. Expects Revisions to Previously Announced 2017 4Q and Full Yr Results; 14/05/2018 – Calumet Specialty Products Partners, L.P. to File its Form 10-Q on May 15th and Will Host First Quarter Financial Results Confe; 15/05/2018 – Calumet Specialty Prods 1Q Loss/Shr 4c

More notable recent The Clorox Company (NYSE:CLX) news were published by: Seekingalpha.com which released: “More on Clorox’s Q2 bottom-line beat – Seeking Alpha” on February 04, 2019, also Seekingalpha.com with their article: “The Clorox Company: 1 Top Dividend Stock For 2019… And Beyond – Seeking Alpha” published on January 15, 2019, Benzinga.com published: “Raymond James Still Sidelined As Clorox Cleans Up Prices, Gross Margins (NYSE:CLX) – Benzinga” on February 05, 2019. More interesting news about The Clorox Company (NYSE:CLX) were released by: Globenewswire.com and their article: “Factors of Influence in 2019, Key Indicators and Opportunity within Helmerich & Payne, Genworth Financial, PBF Energy, EastGroup Properties, Helix Energy, and The Clorox — New Research Emphasizes Economic Growth – GlobeNewswire” published on February 08, 2019 as well as Benzinga.com‘s news article titled: “Clorox Company (The) (NYSE:CLX), Chevron Corporation (NYSE:CVX) – Highlight Reel Looks Light: Alphabet Reporting Later, But Early Action A Bit Slow – Benzinga” with publication date: February 04, 2019.

Since August 13, 2018, it had 0 insider buys, and 13 sales for $53.81 million activity. The insider Willoughby Dawn C sold 25,950 shares worth $4.27M. Costello Michael R. sold $1.10M worth of stock or 6,882 shares. $600,487 worth of The Clorox Company (NYSE:CLX) was sold by Baker Jeff. The insider Barral Diego J sold $2.03M. The insider Rendle Linda J sold 382 shares worth $56,657. 18,366 shares valued at $3.00M were sold by GARNER DENISE on Thursday, December 6. 13,485 shares were sold by Laszlo Matthew T, worth $2.17M.

Nuance Investments Llc decreased Abbott Labs (NYSE:ABT) stake by 182,018 shares to 141,227 valued at $10.36 million in 2018Q3. It also reduced Diageo P L C (NYSE:DEO) stake by 83,288 shares and now owns 273,668 shares. 3M Co (NYSE:MMM) was reduced too.

Among 6 analysts covering Clorox (NYSE:CLX), 2 have Buy rating, 1 Sell and 3 Hold. Therefore 33% are positive. Clorox had 9 analyst reports since September 20, 2018 according to SRatingsIntel. On Tuesday, November 20 the stock rating was maintained by Citigroup with “Neutral”. BMO Capital Markets maintained The Clorox Company (NYSE:CLX) rating on Friday, November 2. BMO Capital Markets has “Outperform” rating and $165 target. The stock of The Clorox Company (NYSE:CLX) has “Market Perform” rating given on Wednesday, October 17 by Wells Fargo. The firm has “Sell” rating by Deutsche Bank given on Wednesday, October 10. The firm has “Market Perform” rating given on Wednesday, December 12 by Wells Fargo. The rating was maintained by Deutsche Bank on Thursday, November 1 with “Sell”. The firm has “Buy” rating by Argus Research given on Tuesday, September 25. The company was maintained on Friday, November 2 by Citigroup.

Investors sentiment decreased to 0.86 in 2018 Q3. Its down 0.14, from 1 in 2018Q2. It is negative, as 39 investors sold CLX shares while 270 reduced holdings. 84 funds opened positions while 181 raised stakes. 95.79 million shares or 1.06% less from 96.82 million shares in 2018Q2 were reported. Choate Investment Advsrs holds 0.01% or 1,479 shares. 6,290 are held by Veritable L P. Aspiriant Ltd Co has invested 0.03% of its portfolio in The Clorox Company (NYSE:CLX). Boothbay Fund Ltd holds 2,088 shares. Smithfield Communication owns 705 shares. Aull & Monroe Invest Management Corp has 0.15% invested in The Clorox Company (NYSE:CLX). Commonwealth Fincl Bank Of Aus owns 9,946 shares. Putnam Investments Ltd Liability reported 0.01% of its portfolio in The Clorox Company (NYSE:CLX). Reilly Herbert Faulkner Iii invested 2.79% in The Clorox Company (NYSE:CLX). Lvm Cap Management Mi accumulated 3,117 shares. Fjarde Ap has invested 0.08% of its portfolio in The Clorox Company (NYSE:CLX). Mackay Shields Lc, a New York-based fund reported 20,428 shares. Rhode Island-based Parsons Management Incorporated Ri has invested 0.15% in The Clorox Company (NYSE:CLX). Green Square Ltd Llc reported 2,650 shares. Jefferies Gp Lc reported 9,812 shares stake.

Since August 15, 2018, it had 10 insider buys, and 0 sales for $315,777 activity. 800 shares were bought by Go Timothy, worth $5,360 on Tuesday, August 21. Griffin David West bought $45,850 worth of stock or 7,000 shares. Shares for $41,650 were bought by William A Anderson on Monday, November 19.

More notable recent Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT) news were published by: Seekingalpha.com which released: “Calumet in year three of ‘incredible’ turnaround, Rhizome Partners says – Seeking Alpha” on August 09, 2018, also Seekingalpha.com with their article: “Calumet Specialty Products Partners, L.P. 2018 Q3 – Results – Earnings Call Slides – Seeking Alpha” published on November 09, 2018, Seekingalpha.com published: “Calumet Specialty Products Partners: It’s About Execution – Seeking Alpha” on November 19, 2018. More interesting news about Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT) were released by: Seekingalpha.com and their article: “Calumet Specialty Products Heading Dramatically Higher – Seeking Alpha” published on July 10, 2018 as well as Seekingalpha.com‘s news article titled: “Calumet Specialty Products Partners: Is The Worst Behind It? – Seeking Alpha” with publication date: November 30, 2018.

Investors sentiment increased to 1 in 2018 Q3. Its up 0.46, from 0.54 in 2018Q2. It improved, as 8 investors sold CLMT shares while 14 reduced holdings. 7 funds opened positions while 15 raised stakes. 9.72 million shares or 5.60% more from 9.20 million shares in 2018Q2 were reported. Eqis Cap Management has invested 0.01% in Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT). Knott David M has invested 3.03% in Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT). Grp One Trading Limited Partnership accumulated 833,581 shares. Bessemer Gp owns 2,000 shares. The North Carolina-based State Bank Of America Corp De has invested 0% in Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT). Raymond James And Assocs invested in 0% or 27,747 shares. Ameriprise has invested 0% of its portfolio in Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT). Goldman Sachs Grp invested 0% of its portfolio in Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT). Susquehanna Gru Llp owns 942,467 shares. Two Sigma Ltd Liability Co holds 12,727 shares or 0% of its portfolio. Wells Fargo & Comm Mn has invested 0% in Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT). Citigroup accumulated 166,728 shares. Raymond James Fin Advisors owns 15,982 shares. Barnett And Co Inc holds 1.19% of its portfolio in Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT) for 407,300 shares. Destination Wealth Mgmt has invested 0% in Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT).

Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.